{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:06:44Z","timestamp":1760044004774},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1985,3,1]],"date-time":"1985-03-01T00:00:00Z","timestamp":478483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1985,3]]},"DOI":"10.1007\/bf00547427","type":"journal-article","created":{"date-parts":[[2004,11,19]],"date-time":"2004-11-19T09:58:27Z","timestamp":1100858307000},"page":"225-229","source":"Crossref","is-referenced-by-count":2,"title":["High performance liquid chromatographic determination of moxalactam in human plasma and cerebrospinal fluid"],"prefix":"10.1007","volume":"29","author":[{"given":"J.","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Karlaganis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. M.","family":"von Hattingberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U. B.","family":"Schaad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF02019617","volume":"1","author":"PC Appelbaum","year":"1982","unstructured":"Appelbaum PC, Tamim J, Stravitz J, Aber RC, Pankuch GA (1982) Sensitivity of 341 non-fermentative gram-negative bacteria to seven beta-lactam antibiotics. Eur J Clin Microbiol 1: 159?165","journal-title":"Eur J Clin Microbiol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1128\/AAC.19.4.575","volume":"19","author":"GR Aronoff","year":"1981","unstructured":"Aronoff GR, Sloan RS, Mong SA, Luft FC, Kleit SA (1981) Moxalactam pharmacokinetics during hemodialysis. Antimicrob Agents Chemother 19: 575?577","journal-title":"Antimicrob Agents Chemother"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/infdis\/145.3.365","volume":"145","author":"GR Aronoff","year":"1982","unstructured":"Aronoff GR, Sloan RS, Luft FC (1982) Pharmacokinetics of moxalactam in patients with normal and impaired renal function. J Infect Dis 145: 365?369","journal-title":"J Infect Dis"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/jac\/6.6.775","volume":"6","author":"AL Barry","year":"1980","unstructured":"Barry AL, Thornsberry C, Jones RN (1980) In vitro evaluation of LY 127935 (6059S) compared with cefotaxime, eight other ?-lactams and two aminoglycosides. J Antimicrob Chemother 6: 775?784","journal-title":"J Antimicrob Chemother"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00007691-198103000-00011","volume":"3","author":"WF Diven","year":"1981","unstructured":"Diven WF, Obermeyer BD, Wolen RL, Yu VL, Lyon J, Zuravleff J (1981) Measurement of serum and tissue concentration of moxalactam using high pressure liquid chromatography. Therap Drug Monit 3: 291?295","journal-title":"Therap Drug Monit"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/infdis\/148.5.886","volume":"148","author":"JM Freedman","year":"1983","unstructured":"Freedman JM, Hoffman SH, Scheld WM, Lynch MA, da Silva HR, Rocha H, Sande MA (1983) Moxalactam for the treatment of bacterial meningitis in children. J Infect Dis 148: 886?891","journal-title":"J Infect Dis"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF00566536","volume":"11","author":"HM Hattingberg von","year":"1977","unstructured":"von Hattingberg HM, Brockmeier D, Kreuter G (1977) A rotating iterative procedure (RIP) for estimating hybrid constants in multi-compartment analysis on desk computers. Eur J Clin Pharmacol 11: 381?388","journal-title":"Eur J Clin Pharmacol"},{"key":"CR8","first-page":"165","volume-title":"25 Years of pharmacokinetics","author":"HM Hattingberg von","year":"1980","unstructured":"von Hattingberg HM, Brockmeier D (1980) Drug concentration control and pharmacokinetic analysis during long term therapy with desk top computers. In: Gladtke E, Heimann G (eds) ?25 Years of pharmacokinetics?. Fischer, Stuttgart, pp 165?179"},{"key":"CR9","first-page":"162","volume":"24","author":"HM Hattingberg von","year":"1983","unstructured":"von Hattingberg HM, Roos R, Brockmeier D, Marget W (1983) Die Ermittlung pharmakokinetischer Parameter aus \u00dcberwachungsprotokollen einer Sepsistherapie. Internist 24: 162?166","journal-title":"Internist"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1128\/AAC.22.6.985","volume":"22","author":"RN Jones","year":"1982","unstructured":"Jones RN, Packer RR (1982) Antimicrobial activity of amikacin combinations against Enterobacteriaceae moderately susceptible to third-generation cephalosporins. Antimicrob Agents Chemother 22: 985?989","journal-title":"Antimicrob Agents Chemother"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0022-3476(81)80562-8","volume":"98","author":"SL Kaplan","year":"1981","unstructured":"Kaplan SL, Mason EO, Garcia H, Kvernland SJ, Loiselle EM, Anderson DC, Mintz AA, Feigin RD (1981) Pharmacokinetics and cerebrospinal fluid penetration of moxalactam in children with bacterial meningitis. J Pediatr 98: 152?157","journal-title":"J Pediatr"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1542\/peds.71.2.187","volume":"71","author":"SL Kaplan","year":"1983","unstructured":"Kaplan SL, Mason EO, Kvernland SJ, Loiselle EM, Feigin RD (1983) Moxalactam treatment of serious infections primarily due to Haemophilus influenzae Type B in children. Pediatrics 71: 187?191","journal-title":"Pediatrics"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1128\/AAC.19.3.461","volume":"19","author":"M Lam","year":"1981","unstructured":"Lam M, Manion CV, Czerwinski AW (1981) Pharmacokinetics of moxalactam in patients with renal insufficiency. Antimicrob Agents Chemother 19: 461?464","journal-title":"Antimicrob Agents Chemother"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0002-9343(80)90505-7","volume":"69","author":"SH Landesman","year":"1980","unstructured":"Landesman SH, Corrado ML, Cherubin CC, Gombert M, Cleri D (1980) Diffusion of a new beta-lactam (Ly 127935) into cerebrospinal fluid. Implications for therapy of gram-negative bacillary meningitis. Am J Med 69: 92?98","journal-title":"Am J Med"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000457446","volume":"3","author":"R Latif","year":"1981","unstructured":"Latif R, Thirumoorthi MC, Buckley JA, Kobos DM, Aravind MK, Kauffman RE, Dajani AS (1981) Pharmacokinetics and clinical evaluation of moxalactam in infants and children. Dev Pharmacol Ther 3: 222?231","journal-title":"Dev Pharmacol Ther"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1128\/AAC.19.1.51","volume":"19","author":"TJ Marrie","year":"1981","unstructured":"Marrie TJ, Haldane EV, Swantee CA, Kerr EA (1981) Susceptibility of anaerobic bacteria to nine antimicrobial agents and demonstration of decreased susceptibility of Clostridium perfringens to penicillin. Antimicrob Agents Chemother 19: 51?55","journal-title":"Antimicrob Agents Chemother"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1128\/AAC.20.2.231","volume":"20","author":"OV Martinez","year":"1981","unstructured":"Martinez OV, Levi JU, Livingstone A, Malinin TI, Zeppa R, Hutson D, Einhorn N (1981) Biliary excretion of moxalactam. Antimicrob Agents Chemother 20: 231?234","journal-title":"Antimicrob Agents Chemother"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1128\/AAC.20.2.252","volume":"20","author":"DJ Miner","year":"1981","unstructured":"Miner DJ, Coleman DL, Sheperd AMM, Hardin TC (1981) Determination of moxalactam in human body fluids by liquid chromatographic and microbiological methods. Antimicrob Agents Chemother 20: 252?257","journal-title":"Antimicrob Agents Chemother"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1128\/AAC.24.3.383","volume":"24","author":"MD Reed","year":"1983","unstructured":"Reed MD, Aronoff SC, Myers CM, Husak MP, Bertino JS Jr, Blumer JL (1983) Developmental pharmacokinetics of moxalactam. Antimicrob Agents Chemother 24: 383?387","journal-title":"Antimicrob Agents Chemother"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1128\/AAC.17.3.406","volume":"17","author":"UB Schaad","year":"1980","unstructured":"Schaad UB, McCracken GH, Loock CA, Thomas ML (1980) Pharmacokinetics and bacteriological efficacy of moxalactam (LY 127935), netilmicin and ampicillin in experimental gramnegative enteric bacillary meningitis. Antimicrob Agents Chemother 17: 406?411","journal-title":"Antimicrob Agents Chemother"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/infdis\/143.2.156","volume":"143","author":"UB Schaad","year":"1981","unstructured":"Schaad UB, McCracken GH, Loock CA, Thomas ML (1981) Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone and rocephin in experimental bacterial meningitis. J Infect Dis 143: 156?163","journal-title":"J Infect Dis"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0022-3476(81)80559-8","volume":"98","author":"UB Schaad","year":"1981","unstructured":"Schaad UB, McCracken GH, Threlkeld N, Thomas ML (1981) Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants. J Pediatr 98: 129?136","journal-title":"J Pediatr"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1128\/AAC.18.3.476","volume":"18","author":"S Shelton","year":"1980","unstructured":"Shelton S, Nelson JD, McCracken GH (1980) In vitro susceptibility of gram-negative bacilli from pediatric patients to moxalactam, cefotaxime, Ro 13-9904 and other cephalosporins. Antimicrob Agents Chemother 18: 476?479","journal-title":"Antimicrob Agents Chemother"},{"key":"CR24","first-page":"109","volume-title":"Current chemotherapy and infectious disease","author":"J Shimada","year":"1980","unstructured":"Shimada J, Ueda Y, Yamaji T, Abe Y, Nakamura M (1980) Renal excretion of 6059-S, a new semisynthetic beta-lactam antibiotic. In: Nelson JD and Grassi C (eds) Current chemotherapy and infectious disease. American Societiy for Microbiology, Washington DC, p 109?110"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0022-3476(81)80036-4","volume":"99","author":"MC Thirumoorthi","year":"1981","unstructured":"Thirumoorthi MC, Buckley JA, Aravind MK, Kauffman RE, Dajani AS (1981) Diffusion of moxalactam into the cerebrospinal fluid in children with bacterial meningitis. J Pediatr 99: 975?979","journal-title":"J Pediatr"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/archopht.1982.01030030331023","volume":"100","author":"MM Uwaydah","year":"1982","unstructured":"Uwaydah MM, Jabbour N, Fahd S, Jaafar M, Faris BM (1982) Penetration of intravenous moxalactam into human aqueous humor. Arch Ophthalmol 100: 329?330","journal-title":"Arch Ophthalmol"},{"issue":"Suppl","key":"CR27","doi-asserted-by":"crossref","first-page":"S564","DOI":"10.1093\/clinids\/4.Supplement_3.S564","volume":"4","author":"R Wise","year":"1982","unstructured":"Wise R, Wright N, Wills PJ (1982) Activity, stability, and pharmacology of the epimers of moxalactam. Rev Infect Dis 4 [Suppl]: S564-S568","journal-title":"Rev Infect Dis"},{"issue":"Suppl","key":"CR28","doi-asserted-by":"crossref","first-page":"S610","DOI":"10.1093\/clinids\/4.Supplement_3.S610","volume":"4","author":"DH Wittmann","year":"1982","unstructured":"Wittmann DH, Schassan HH (1982) Distribution of moxalactam in serum, bone, tissue fluid, and peritoneal fluid. Rev Infect Dis 4 [Suppl]: S610-S616","journal-title":"Rev Infect Dis"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00547427.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00547427\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00547427","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T10:12:00Z","timestamp":1682849520000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00547427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,3]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1985,3]]}},"alternative-id":["BF00547427"],"URL":"https:\/\/doi.org\/10.1007\/bf00547427","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,3]]}}}